Clinical Trial Update: Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa [Phase 2, Phase 3]

View source ↗

Summary

This is an update on a Phase 2/3 clinical trial evaluating high-dose fluconazole in combination with flucytosine as induction therapy for cryptococcal meningiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis
• HIV Infection

Drugs mentioned

• Fluconazole (Fluconazole)
• Flucytosine (flucytosine)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Cryptococcal Meningitis, HIV | Phase 2, Phase 3 | Status: UNKNOWN